CD83 and lung cancer: DC-based HHP lung cancer vaccine was not functionally exhausted by the first maturation stimuli with poly(I:C) as DC enhanced the expression of maturation associated molecules CD80 and CD83 and IL-12p70 production in response to LPS and CD40L [4, 33, 34].